Mississauga, ON -- (SBWIRE) -- 12/17/2015 -- AllPennyStocks.com Media, Inc. (http://www.AllPennyStocks.com/) announces its latest article titled "Matinas BioPharma's MAT2203 Granted QIDP and Fast Track Designation by FDA."
Companies mentioned in this article include iShares NASDAQ Biotechnology (ETF) (NASDAQ:IBB) and
Matinas BioPharma Holdings Inc. (OTCQB:MTNB).
Article Excerpt:
The biotech sector has had a mixed year. The sector has come under significant selling pressure since July this year. The initial pullback in the biotech sector was due to concerns over high valuations in the sector. Then in September this year, the sector saw another sharp pullback after Democratic Presidential candidate Hillary Clinton tweeted about the drug pricing issue.
Indeed, lawmakers have been critical of some of the practices of the biotech sector, including pricing of some of the drugs. All these factors, combined with a rate hike from the Federal Reserve, is keeping the biotech sector under pressure. It must be noted though that the iShares NASDAQ Biotechnology (ETF) (NASDAQ:IBB) is still up more than 10% for the year, outperforming the broader market.
The full version of this article can be found at:
http://www.allpennystocks.com/aps_us/special-reports/597/matinas-biopharmas-mat2203-granted-qidp-and-fast-track-designation-by-fda.htm
About AllPennyStocks.com
AllPennyStocks.com is focused on the small-cap / penny stock market and has become a reputable name in the investment community. AllPennyStocks.com runs a Canadian and US site to provide investors in Canada as well as the United States with informative and unique content and information. AllPennyStocks.com runs daily technical penny stocks to watch, has a daily market write-up, provides company spotlights, runs unique most active pages strictly for penny stocks trading on the TSX, TSX Venture, NASDAQ and OTC BB, and much more information for the average investor.
AllPennyStocks.com also runs an email newsletter that aims to uncover stocks that are still under the radar of most investors. Criteria AllPennyStocks.com looks for includes strong revenues, a seasoned management, innovative business plans, among many others. AllPennyStocks.com also looks for companies that announce breaking news, recent 52-week highs/lows, technical breakouts, and other favorable corporate information.
Investors are encouraged to subscribe to the AllPennyStocks.com FREE e-mail newsletter and see what tens of thousands of other investors have already been receiving since 1999. Investors can receive their free newsletter subscription by clicking here: http://www.allpennystocks.com/aps_common/newsletter_free.asp.
Contact:
AllPennyStocks.com Media, Inc.
Peter Szafranski -- President
Phone: (905) 361-5680
E-Mail: peter@allpennystocks.com
Websites: http://www.allpennystocks.com / http://www.bullishinvestor.com
Note: AllPennyStocks.com has not received compensation for carrying the above-mentioned company; a full disclaimer can be viewed here: http://www.allpennystocks.com/aps_common/disclaimer.asp.